Antirheumatic Agents Concept

subject area of

• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis  Academic Article
• 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis  Academic Article
• 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty  Academic Article
• 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty  Academic Article
• 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty  Academic Article
• 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis  Academic Article
• 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis  Academic Article
• 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases  Academic Article
• 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis  Academic Article
• 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis  Academic Article
• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis  Academic Article
• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa  Academic Article
• 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases  Academic Article
• 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases  Academic Article
• A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial  Academic Article
• A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry  Academic Article
• Achieving remission in clinical practice: lessons from clinical trial data.  Academic Article
• Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine: First Case Report in Canada and Review of the Literature  Academic Article
• Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort  Academic Article
• American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis  Academic Article
• An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance  Academic Article
• An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis  Academic Article
• Antiretroviral resistance testing in HIV-positive people  Academic Article
• Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort  Academic Article
• Assessment of reproductive history in systemic sclerosis  Academic Article
• Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage  Academic Article
• Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis  Academic Article
• Auranofin  Academic Article
• BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics  Academic Article
• Back to the future: the pyramids of rheumatoid arthritis.  Academic Article
• Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis  Academic Article
• Biologic therapies and bone loss in rheumatoid arthritis  Academic Article
• Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors  Academic Article
• Can observational studies replace or complement experiment?  Academic Article
• Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study  Academic Article
• Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database  Academic Article
• Clinical Practice Guidelines: Incorporating Input From a Patient Panel  Academic Article
• Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.  Academic Article
• Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections  Academic Article
• Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative—a rheumatoid arthritis cohort  Academic Article
• Community-based evaluation of etanercept in patients with rheumatoid arthritis.  Academic Article
• Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions  Academic Article
• Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.  Academic Article
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Academic Article
• Dealing with Drug-Induced Thrombocytopenia  Academic Article
• Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process  Academic Article
• Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada  Academic Article
• Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: Results from a real-world rheumatoid arthritis cohort  Academic Article
• Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?  Academic Article
• Earlier Time to Remission Predicts Sustained Clinical Remission in Early Rheumatoid Arthritis — Results from the Canadian Early Arthritis Cohort (CATCH)  Academic Article
• Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results  Academic Article
• Effect of menopause on the modified Rodnan skin score in systemic sclerosis  Academic Article
• Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study  Academic Article
• Elevated concentrations of circulating cytokines and correlations with nerve conduction velocity in human peripheral nerves  Academic Article
• Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis  Academic Article
• Evidence-Based Guideline: ACR made 10 strong treatment recommendations for RA, but high-quality evidence was sparse  Academic Article
• Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.  Academic Article
• Gap Between Official Guidelines and Clinical Practice for the Treatment of Rheumatoid Arthritis in São Paulo, Brazil  Academic Article
• Health Assessment Questionnaire at One Year Predicts All‐Cause Mortality in Patients With Early Rheumatoid Arthritis  Academic Article
• Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts  Academic Article
• High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years  Academic Article
• How to Ascertain Drug Safety in the Context of Benefit. Controversies and Concerns: Table 1.  Academic Article
• Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America  Academic Article
• Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study.  Academic Article
• Increased risk of mycobacterial infections associated with anti-rheumatic medications  Academic Article
• Increasing Treatment in Early Rheumatoid Arthritis Is Not Determined by the Disease Activity Score But by Physician Global Assessment: Results from the CATCH Study  Academic Article
• Intramuscular Methotrexate-Induced Aseptic Meningitis  Academic Article
• Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)  Academic Article
• Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis  Academic Article
• Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience  Academic Article
• Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association  Academic Article
• Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries  Academic Article
• Matrix catabolism in arthritis: priming the guns with oncostatin M.  Academic Article
• Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials  Academic Article
• Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort  Academic Article
• Modified intention-to-treat analysis did not bias trial results  Academic Article
• Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients  Academic Article
• Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting  Conference Paper
• Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol  Academic Article
• Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA  Academic Article
• Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study  Academic Article
• Oxaprozin: kinetic and dynamic profile in the treatment of pain  Academic Article
• Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry  Academic Article
• Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario  Academic Article
• Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort  Academic Article
• Preventing Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis—Reply  Academic Article
• Psoriasis in systemic lupus erythematosus: a single-center experience  Academic Article
• Quality care in seniors with new-onset rheumatoid arthritis: A Canadian perspective  Academic Article
• Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines  Academic Article
• Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with Infliximab  Academic Article
• Refractory urticaria and the importance of diagnosing Schnitzler’s syndrome  Academic Article
• Reply  Academic Article
• Reply to: methotrexate and not much harm to the lungs by H. Yazici.  Academic Article
• Response times follow lognormal or gamma distribution in arthritis patients  Academic Article
• Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis  Academic Article
• Responses of the colonic epithelium to auranofin: evidence for involvement of enteric nerves.  Academic Article
• Responsiveness of endpoints in osteoporosis clinical trials--an update.  Academic Article
• Rheumatoid Arthritis Is Associated With Increased Aortic Pulse-Wave Velocity, Which Is Reduced by Anti–Tumor Necrosis Factor-α Therapy  Academic Article
• Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis  Academic Article
• Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study  Academic Article
• Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience  Academic Article
• Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort  Academic Article
• Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis  Academic Article
• Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?  Academic Article
• Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin  Academic Article
• TNF-α −308 G/A polymorphism and responsiveness to TNF-α blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis  Academic Article
• The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery  Academic Article
• The biological activity of auranofin: implications for novel treatment of diseases  Academic Article
• The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis  Academic Article
• The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort  Academic Article
• The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort  Academic Article
• Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases  Academic Article
• Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study  Academic Article
• Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort  Academic Article
• Trying to Improve Care: The Morbidity and Mortality Conference in a Division of Rheumatology  Academic Article
• Tumor Necrosis Factor Inhibitor Dose Reduction for Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials  Academic Article
• Understanding Preferences for Disease-Modifying Drugs in Osteoarthritis  Academic Article
• Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study  Academic Article
• Use of abatacept in eosinophilic asthma  Academic Article
• Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort  Academic Article
• Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings  Academic Article